Term ends Jun 25, 2031 · Low confidence
20-year base term ends Jun 25, 2031
Filed Sep 26, 2017 as application 15/715,748 · Granted Jul 20, 2021
Base term, 20 years from filing
Today
2011
2031
Clock starts
Jun 25, 2011
Jun 25, 2011
Term ends
Jun 25, 2031
Jun 25, 2031
Granted
Jul 20, 2021
Jul 20, 2021
base term
fee events
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 8,580,922, US 9,814,764, US 9,932,568, to Jun 25, 2031. The term already ends on or before that date, so the cap shortened nothing.
1 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
9
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 1 of 2 maintenance fees is paid so far. Confidence: Low. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jun 25, 2011, when application 13/168,969, the earliest non-provisional in its chain, was filed (this one was filed Sep 26, 2017); a parent in its chain could not be resolved (the next row) | Jun 25, 2031 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 8,580,922, US 9,814,764, US 9,932,568) | resolves to Jun 25, 2031, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 2 maintenance fees paid | In force | High confidence |
| Further caveats on record | The record names parents not resolved: 13168969, 13168969 | Low confidence overall | Low confidence |
| Computed term end | The steps above, in order | Jun 25, 2031 | Low confidence |
This family
| Application 13/168,969 | Abandoned not computed | not computed |
| Application PCT/US2011/041928 | PCT application no patent term | no patent term |
| US 8,580,922 | In force Jun 2031 | Jun 2031 |
| Application PCT/US2012/027561 | PCT application no patent term | no patent term |
| US 9,814,764 | In force Aug 2031 | Aug 2031 |
| US 9,206,235 | In force no later than Jul 2031 | no later than Jul 2031 |
| US 9,932,568 | In force Nov 2031 | Nov 2031 |
| US 11,065,307 | this patent Jun 2031 | Jun 2031 |
8 of 9 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Dec 20, 2017 Reel 44451, frame 189 | Concino, Michael F.; Calias, Pericles; Pan, Jing; Holmes, Kevin; Martini, Paolo; Romashko, Alla; Meiyappan, Muthuraman; Zhang, Bohong; Iskenderian, Andrea; Lundberg, Dianna; Norton, Angela; Strack-logue, Bettina; Yan, Huang; Alessandrini, Mary; Pfeifer, Richard | Shire Human Genetic Therapies, Inc. | Assignment of Assignor's Interest |
| Sep 15, 2022 Reel 61447, frame 760 | Shire Human Genetic Therapies, Inc. | Takeda Pharmaceutical Company Limited | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Jun 2031
Term ends Jun 25, 2031. Maintenance fees still fall due before then
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 8,580,922, US 9,814,764, US 9,932,568, ends no earlier than this term, so it caps nothing.
Citations
7
later US patents cite this one
That is top 25% of utility patents granted in 2021 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.